LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio welcomes renewed commitment to the EU Bioeconomy

    11/10/2018
    PRESS RELEASE

    EuropaBio welcomes renewed commitment to the EU Bioeconomy

    EuropaBio is pleased to welcome the publication of an updated EU Bioeconomy Strategy.

    Brussels 11 October 2018 Today, EuropaBio is pleased to welcome the publication of an updated EU Bioeconomy Strategy. The updated plan signals the EU’s continued commitment towards establishing itself as a world leader in renewable resource efficiency, catalysed by transformative industrial biotechnology.

    Europe’s leadership in this field has already significantly boosted activity, investment, technological breakthrough and interest in developing dynamic bioeconomies throughout the Member States and regions.

    An innovation-driven bioeconomy, with increased sustainability as its end goal, is now also providing renewability, circularity and multifunctionality whilst helping to deliver solutions to the UN SDGs. Industrial biotechnology plays a central role as an enabling technology, using smart science to develop a wide variety of renewable, bio-based chemicals, materials, pharmaceuticals, food, feed and fuels.

    Since the publication of the first EU strategy in 2012, the increase in EU R&I funds has also resulted in real progress towards the development of a bio-based economy, with the €3.7 billion Bio-based Industries Joint Undertaking (BBI JU) attracting investments, spurring innovation and creating new value chains.

    Commenting on the strategy launch, Agnes Borg, Director for Industrial Biotechnology at EuropaBio said: “We now call on the EU to shore up the updated strategy with a comprehensive high-level commitment towards building upon the success of the BBI JU. This will create jobs and growth and will help establish the EU as hub for renewable, resource efficient clean-tech on the road to 2030”.

    EuropaBio welcomes renewed commitment to the EU Bioeconomy


    Download
    Share
    Communications Team
    Communications Team

    Related posts

    06/03/2026

    Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe


    Read more
    13/02/2026

    The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies


    Read more
    11/02/2026

    Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026


    Read more

    Important links

    • Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe
    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.